Recent Updates
Recently added Catalysts
RANI Positive Sentiment

Rani Therapeutics Appoints Michelle Gilson to Board of Directors

Tuesday, August 4, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Rani Therapeutics has appointed Michelle Gilson to its Board of Directors. Gilson, the former Chief Financial Officer of Arcellx, brings significant expertise in capital markets and biotech financial leadership. This appointment is expected to bolster the company's strategic direction as it focuses on the oral delivery of biologics.

Market Sentiment Analysis

POSITIVE FACTORS

  • Appointment of Michelle Gilson enhances leadership team.
  • Brings extensive experience in capital markets and biotech.
  • Strengthens Rani Therapeutics' strategic direction.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~22 mo
Low dilution risk
Lead asset
Stelara
Phase 1 · Healthy Volunteers

Full Press Release Details

~ Former Chief Financial Officer of Arcellx Brings Deep Capital Markets and Biotech Financial Leadership Experience ~ SAN JOSE, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics,

Frequently Asked Questions

Who is Michelle Gilson?

Michelle Gilson is the former Chief Financial Officer of Arcellx.

What is Rani Therapeutics focused on?

Rani Therapeutics focuses on the oral delivery of biologics.

What role has Michelle Gilson been appointed to?

She has been appointed to the Board of Directors of Rani Therapeutics.

What experience does Michelle Gilson bring?

She brings deep capital markets and biotech financial leadership experience.

ShareAdd on Google
Tags: RANI Viatris Investor Conferences Healthcare Rani Therapeutics Michelle Gilson biotech leadership board of directors capital markets
Last updated: Aug 4, 2026

Biotech snapshot

Cash runway
$52M liquidity · $2M/mo burn
~22 mo
Low dilution risk
Lead asset
StelaraPhase 1
Healthy Volunteers →